Targeting lipid rafts for treatment of migraine

Ended Project Grant Awarded Last action

Award ID
R41NS113705
Recipient
Awarding agency
Obligated
$665,674

Award facts

Assistance listing
93.279 Drug Use and Addiction Research Programs
Completion date
Originally
Place of performance
San Diego, CA 92121, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Original award $665,674

Subawards

Subrecipient Amount Awarded
University Of Texas At Dallas Experiments performed at UTD under this subcontract from Raft Pharmaceuticals will test the AIBP compound in the repeated-stress induced migraine model. The… $37,730
The Regents Of The University Of California, San Diego PROJECT SUMMARY Migraine is a highly prevalent condition with an extraordinarily negative impact on quality of life and represents a heavy socioeconomic… $301,183

Quick answers

Who received award R41NS113705?

R41NS113705 was awarded to Raft Pharmaceuticals LLC by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on September 30, 2019.

How much is award R41NS113705 worth?

$665,674 has been obligated on R41NS113705.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login